CRYSTALLINE FORM OF IBRUTINIB
The present invention relates to crystalline form of ibrutinib, designated as Form K1, and processes for its preparation. La présente invention concerne une forme cristalline d'ibrutinib, appelée forme K1, et des procédés pour sa préparation.
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BERGANT SIMONCIC, Ana KUFNER, Monika KLEMENT, Dejan HROVAT, Sara BENKIC, Primož |
| description | The present invention relates to crystalline form of ibrutinib, designated as Form K1, and processes for its preparation.
La présente invention concerne une forme cristalline d'ibrutinib, appelée forme K1, et des procédés pour sa préparation. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023242384A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023242384A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023242384A13</originalsourceid><addsrcrecordid>eNrjZJB1DooMDnH08fH0c1Vw8w_yVfB3U_B0CgoN8fTzdOJhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRsZGJkbGFiaOhsbEqQIAHpkiCw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE FORM OF IBRUTINIB</title><source>esp@cenet</source><creator>BERGANT SIMONCIC, Ana ; KUFNER, Monika ; KLEMENT, Dejan ; HROVAT, Sara ; BENKIC, Primož</creator><creatorcontrib>BERGANT SIMONCIC, Ana ; KUFNER, Monika ; KLEMENT, Dejan ; HROVAT, Sara ; BENKIC, Primož</creatorcontrib><description>The present invention relates to crystalline form of ibrutinib, designated as Form K1, and processes for its preparation.
La présente invention concerne une forme cristalline d'ibrutinib, appelée forme K1, et des procédés pour sa préparation.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231221&DB=EPODOC&CC=WO&NR=2023242384A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231221&DB=EPODOC&CC=WO&NR=2023242384A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BERGANT SIMONCIC, Ana</creatorcontrib><creatorcontrib>KUFNER, Monika</creatorcontrib><creatorcontrib>KLEMENT, Dejan</creatorcontrib><creatorcontrib>HROVAT, Sara</creatorcontrib><creatorcontrib>BENKIC, Primož</creatorcontrib><title>CRYSTALLINE FORM OF IBRUTINIB</title><description>The present invention relates to crystalline form of ibrutinib, designated as Form K1, and processes for its preparation.
La présente invention concerne une forme cristalline d'ibrutinib, appelée forme K1, et des procédés pour sa préparation.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB1DooMDnH08fH0c1Vw8w_yVfB3U_B0CgoN8fTzdOJhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRsZGJkbGFiaOhsbEqQIAHpkiCw</recordid><startdate>20231221</startdate><enddate>20231221</enddate><creator>BERGANT SIMONCIC, Ana</creator><creator>KUFNER, Monika</creator><creator>KLEMENT, Dejan</creator><creator>HROVAT, Sara</creator><creator>BENKIC, Primož</creator><scope>EVB</scope></search><sort><creationdate>20231221</creationdate><title>CRYSTALLINE FORM OF IBRUTINIB</title><author>BERGANT SIMONCIC, Ana ; KUFNER, Monika ; KLEMENT, Dejan ; HROVAT, Sara ; BENKIC, Primož</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023242384A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BERGANT SIMONCIC, Ana</creatorcontrib><creatorcontrib>KUFNER, Monika</creatorcontrib><creatorcontrib>KLEMENT, Dejan</creatorcontrib><creatorcontrib>HROVAT, Sara</creatorcontrib><creatorcontrib>BENKIC, Primož</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BERGANT SIMONCIC, Ana</au><au>KUFNER, Monika</au><au>KLEMENT, Dejan</au><au>HROVAT, Sara</au><au>BENKIC, Primož</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE FORM OF IBRUTINIB</title><date>2023-12-21</date><risdate>2023</risdate><abstract>The present invention relates to crystalline form of ibrutinib, designated as Form K1, and processes for its preparation.
La présente invention concerne une forme cristalline d'ibrutinib, appelée forme K1, et des procédés pour sa préparation.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023242384A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CRYSTALLINE FORM OF IBRUTINIB |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T18%3A30%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BERGANT%20SIMONCIC,%20Ana&rft.date=2023-12-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023242384A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |